- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05022056
Impact of High-flow Nasal Oxygen During Awake Fiberoptic Bronchoscope Guided Intubation: A Retrospective Study
August 25, 2021 updated by: Yonsei University
Retrospective data collection.
The aim of this study is to investigate impact of high-flow nasal oxygen on safety(lowest oxygen saturation), efficiency (intubation time, need for multiple attempts) in patients underwent awake fiberoptic bronchoscope guided intubation.
Study Overview
Status
Not yet recruiting
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who underwent awake fiberoptic bronchoscope guided intubation for surgery
Description
Inclusion Criteria:
1.Patients who underwent awake fiberoptic bronchoscope guided intubation for surgery
Exclusion Criteria:
- Cases in which other procedures (e.g. arterial line cannulation) were performed prior to endotracheal intubation after entering operation room
- Patients with Incomplete records of oxygen saturation, attempt number, and time taken for awake intubation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intra-procedural lowest saturation
Time Frame: Intra-procedural lowest saturation
|
Intra-procedural lowest saturation: lowest oxygen saturation on pulse oximetry during awake intubation
|
Intra-procedural lowest saturation
|
|
need for multiple attempts
Time Frame: Intra-procedural (need for multiple attempts : during awake intubation)
|
need for multiple attempts : more than 2 attempts needed during awake intubation
|
Intra-procedural (need for multiple attempts : during awake intubation)
|
|
time taken for awake intubation
Time Frame: Intra-procedural (Time taken for awake intubation: time from entering the operating room to completion of awake endotracheal intubation)
|
Time taken for awake intubation: time from entering the operating room to completion of awake endotracheal intubation
|
Intra-procedural (Time taken for awake intubation: time from entering the operating room to completion of awake endotracheal intubation)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
September 1, 2021
Primary Completion (ANTICIPATED)
October 1, 2021
Study Completion (ANTICIPATED)
October 1, 2021
Study Registration Dates
First Submitted
August 24, 2021
First Submitted That Met QC Criteria
August 25, 2021
First Posted (ACTUAL)
August 26, 2021
Study Record Updates
Last Update Posted (ACTUAL)
August 26, 2021
Last Update Submitted That Met QC Criteria
August 25, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 4-2021-0901
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Awake Fiberoptic Bronchoscope Guided Intubation
-
Zagazig UniversityCompletedAwake Fiberoptic IntubationEgypt
-
Zagazig UniversityCompletedAwake Fiberoptic IntubationEgypt
-
Hospira, now a wholly owned subsidiary of PfizerCompletedAwake Fiberoptic IntubationUnited States
-
Johannes Gutenberg University MainzCompletedAwake Fiberoptic IntubationGermany
-
Kaohsiung Medical University Chung-Ho Memorial...UnknownAwake Fiberoptic Nasal IntubationTaiwan
-
Second Military Medical UniversityCompletedTransillumination-guided Fiberoptic Intubation IntubationChina
-
University of Illinois at ChicagoRecruitingDifficult Airway | Awake Fiberoptic IntubationUnited States
-
Tanta UniversityRecruitingSevoflurane | Sedation | Difficult Airway | Awake Fiberoptic IntubationEgypt
-
Kocaeli City HospitalNot yet recruitingVideolaryngoscopy | Awake Fiberoptic Nasal Intubation | Awake Endotracheal Intubation | Airway Management Assessment | Supraglottic Airway Device InsertionTurkey (Türkiye)
-
American University of Beirut Medical CenterCompleted